undamentalytics Newsletter

Medpace Holdings, Inc. balance sheet

At the end of fiscal 2025, Medpace Holdings, Inc. had total assets of $1.98bn, total liabilities of $1.52bn and shareholders' equity of $459m. It held $497m in cash against $0 of debt: net cash of $497m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Medpace Holdings, Inc.: balance sheet, annual
Fiscal year2015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Cash and equivalents1537262313227846128245669497705
Receivables658083133156161186253298296402448
Total current assets951331301783174746913345941,0299901,245
Goodwill661661661661662662662662662662662662
Total assets9849799511,0051,1431,3911,6601,3521,6572,1011,9752,303
Accounts payable91117172227263332332844
Deferred revenue (current)516674148192256345463560711854962
Total current liabilities1341691932633434405578039251,1051,3441,496
Short-term debt012170——0500———
Long-term debt378151205800———————
Total debt39016522380000500000
Total liabilities5713684474064175857079661,0981,2751,5161,718
Shareholders' equity413611509599726806953386559826459585
Net debt (negative = net cash)37512819656−132−278−46122−245−669−497−705
Shares outstanding33m41m35m36m36m36m36m31m31m31m28m28m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: FTRE vs MEDPBIO vs MEDPBRKR vs MEDPMEDP vs QGEN

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Medpace Holdings, Inc.'s SEC filings (10-K and 10-Q), retrieved October 23, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Medpace Holdings, Inc.